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In homeopathy, ability of ultra-high diluted drugs at or above potency 12C (diluted beyond Avogadro’s limit) in ameliorat-
ing/curing various diseases is often questioned, particularly because the mechanism of action is not precisely known. We tested
the hypothesis if suitable modulations of signal proteins could be one of the possible pathways of action of a highly diluted
homeopathic drug, Secale cornutum 30C (diluted 1060 times; Sec cor 30). It could successfully combat DMBA + croton oil-
inducedskinpapillomainmiceasevidencedbyhistological,cytogenetical,immunoﬂuorescence,ELISAandimmunoblotﬁndings.
Critical analysis of several signal proteins like AhR, PCNA, Akt, Bcl-2, Bcl-xL, NF-κB and IL-6 and of pro-apoptotic proteins like
cytochrome c, Bax, Bad, Apaf, caspase-3 and -9 revealed that Sec cor 30 suitably modulated their expression levels along with
amelioration of skin papilloma. FACS data also suggested an increase of cell population at S and G2 phases and decrease in sub-
G1 and G1 phages in carcinogen-treated drug-unfed mice, but these were found to be near normal in the Sec cor 30-fed mice.
There was reduction in genotoxic and DNA damages in bone marrow cells of Sec Cor 30-fed mice, as revealed from cytogenetic
and Comet assays.Changes in histological features of skin papilloma were noted. Immunoﬂuorescence studies of AhR and PCNA
also suggested reduced expression of these proteins in Sec cor 30-fed mice, thereby showing its anti-cancer potentials against
skin papilloma. Furthermore, this study also supports the hypothesis that potentized homeopathic drugs act at gene regulatory
level.
1.Introduction
Convincing positive eﬀects of homeopathic drugs in pre-
vention and treatment of various cancers like prostate [1],
liver [2–5] and Ehrlich ascites carcinoma and Dalton’s
lymphoma[6,7]havebeendocumentedearlierinlaboratory
animals. However, the mechanisms of chemoprevention or
intervention by homeopathic remedies have been debated
over and again and some critics even suggested that the
actions ofthese drugsare no betterthanthe “placebo” eﬀects
[8, 9].
In recent past, clinical trials and laboratory-based exper-
iments have provided evidences that these drugs interfere
with cancerous growth through genetical and physiological
pathways [10–12].
However, despite scientiﬁc evidences and arguments for
and against the eﬃcacy of potentized homeopathic drugs
diluted beyond Avogadro’s limit (potency 12 and above), the
issue has not yet been fully resolved, particularly because
such ultra-high diluted drugs cannot theoretically have even
a single molecule of the original drug substance. But more
recent works [6,7,13]pointingtotheabilityofhighlydiluted
(dynamized) drugs showing positive eﬀects on the face of
their physical non-existence have reopened the search for
other possible molecular pathways of activities. Sunila et al.
[6, 7] addressed this issue in in vitro experimental model
(cancer cell line) and suggested that potentized homeopathic
drugs diluted beyond Avogadro’s limit can modulate certain
signal proteins.2 Evidence-Based Complementary and Alternative Medicine
Analysis of expression of signal proteins, one of the
state-of-the art techniques to understand signaling pathways
[14], has been employed to understand the mechanism
of chemoprevention or intervention by anti-cancer drugs
employing HeLa cancer cell line [15, 16]. However, the
exact signaling pathway through which they possibly act still
remains rather obscure.
With this view in mind, the present work was aimed
at testing the hypothesis if (i) Secale cornutum 30C (Sec
cor-30, diluted 1060 times) could show amelioration of skin
cancer and (ii) to examine if some relevant signal proteins
were suitably modulated during this process. This drug
was chosen because Sec cor-30 is claimed in homeopathic
literature [17] to have great action against any stubborn case
of skin lesions, particularly of hemorrhagic and wrinkled
ulcerationofskin.ADMBA+crotonoil-inducedmouseskin
cancermodelwaschosenforthisstudy,primarilybecausethe
cytokine-mediated cell signaling pathway is well deﬁned in
this model. DMBA is known to induce skin cancer through
ligand-activation of the Aryl hydrocarbon receptor (AhR)
[18–20] and by up-regulation of proliferating cell nuclear
antigen (PCNA) [21, 22]. Thus, the study of expression of
other downstream proteins like IL-6, NF-κB, Bcl-2, Bcl-xL,
Bad, Bax, p53, caspase-3 and -9 could throw signiﬁcant
light on the pathway of carcinogenesis by DMBA + croton
oil application. Furthermore, this could highlight how the
homeopathic drug could, if it did, combat the carcinogenesis
process.
2.Methods
Inbred Swiss albino mice (Mus musculus)o fb o t hg e n d e r s
reared in the animal house under standard hygienic condi-
tions and food were used. The experiments were performed
with clearance from the Ethical Committee, University of
Kalyani and as per the stipulated guidelines. Healthy mice 8–
10 weeks old, weighing between 22 and 26 g were selected
randomly for use in the experiment. The selected mice were
allocated to four groups, each comprising six mice (in two
replicates of three mice each kept in separate cages).
Group 1 (Negative control). mice fed with normal diet and
water ad libitum without any exposure to DMBA+croton
oil.
Group 2 (Treated). 100μg of DMBA was applied once a
week and 1% croton oil was applied twice a week to skin
on dorsal side of the mouse for 24 weeks. Instead of the
generally adopted practice of treating mice with DMBA
for once or twice a week for 4 weeks (for initiation) [23],
followed by regular application of croton oil (for promotion
of papilloma) [24] as a complete carcinogenesis protocol,
the mice in the present investigation were repeatedly treated
with DMBA, once every week for 24 weeks, because: (i)
that would further ensure development of papilloma (with
possibility of many of them turning malignant) and (ii)
we were interested in conducting studies on modulation
of signal protein expression (particularly AhR), if any, as a
result of DMBA and croton oil treatment, and any further
modulation caused by the homeopathic drug [25]. DMBA is
known to activate AhR by acting as a ligand.
Group3(positivecontrol). 100μgofDMBAwas appliedonce
a week and 1% of croton oil was applied twice a week to
skin on dorsal side of the mouse for 24 weeks and fed a daily
dose (two times) of Alcohol-30C, (Alc-30; placebo) through
gavage with the aid of a ﬁne tube.
Group 4 (drug-fed). this group was similarly treated as in
Group 2 but, in addition, they were treated with Sec cor-30.
Each mouse was fed a daily dose (two times) of 0.06ml of
stock solution of Sec cor 30 through gavage with the aid of a
ﬁne tube.
2.1. Preparation of the Potentized Sec cor 30. The potentized
homeopathic drug, Sec cor 30 was procured from HAPCO
(BB Ganguly Street, Kolkata). The placebo, Alc-30, was
preparedfrom thesame stockofalcoholusedforpreparation
of Sec cor 30, as per the standard procedure of homeopathic
principleof“succussionsand dilution.”Onemilliliterofeach
of Sec 30 and Alc-30 was diluted separately with 20ml of
double distilled water to make the stock solution of Sec 30
and Alc-30, respectively.
2.2. Incidence of Skin Tumors. The numbers of tumor
formation in four groups were recorded weekly.
2.3. Histology and Immunoﬂuorescence. Back skin samples
were dissected from the lesion and/or tumor regions of
the mid-dorsal back skin of both the drug-fed and positive
controls (and also of normal back skin of negative control)
andﬁx edinnormalbuﬀerformalin,followedbydehydration
treatment, as per the standard practice [21]. After storing at
room temperature for less than a week in 70% alcohol, the
tissues were washed two times each for 30min in xylene,
and then transferred to the embedding bath. The paraﬃn
blocks were cut into ribbon like pieces and placed on to
slides after stretching into warm water. The paraﬃnw a s
removed by xylene (two washes each for 10min), then the
xylene was removed by alcohols. Processed tissues were
stained in haematoxylin for 2min, followed by washing
in distilled and tap water, respectively. Then tissues were
brought into alcohol medium (70%, 90% two washes each
for 2min), followed by staining with eosin (30 s) and
dehydrated into 90% and absolute alcohol (two washes each
for 2min). Finally, xylene treatment (two washes each for
2min) was carried out, followed by mounting into DPX. For
immunoﬂuorescence study, the technique of Arabzadeh et
al. [26] was adopted with a little modiﬁcation. Brieﬂy, cut
tissue sections were de-paraﬃnized and incubated separately
for 12h with mouse monoclonal AhR and PCNA antibodies,
respectively, procured from Abcam International, USA.
Then after blocking with 3% BSA, the tissue sections were
incubated for 2h with ﬂuorescence isothiocyanite (FITC)
conjugated secondary antibody purchased from Sigma, St.
Louis, MO, USA. The ﬂuorescence intensity of FITC was
measured under ZEISS ﬂuorescence microscope, Germany,
Carl Zeiss MicroImaging, Inc., Thornwood, New York.Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: External morphology of skin of mice: (a) normal; (b) DMBA+croton oil; (c) DMBA+croton oil+alcohol; (d) DMBA+croton
oil+Sec cor 30.
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Figure 2: Number of tumors/mouse plotted as a function of weeks
on test. Each value represents the mean number of tumor per
mouse. ∗∗P <.01, ∗∗∗P <.001.
2.4. Signal Proteins. These were either detected by ELISA
method (caspase-3) or by western blots (the remaining
ones).
2.4.1. Western Blot. It was performed as per protocol
described previously [27]. Brieﬂy, mouse skin tissues were
homogenized in lysis buﬀer containing 50mM Tris-HCl,
pH 8.0, 1% Nonidet P-40, 125mM NaCl, 1mM NaF,
1mM phenylmethylsulfonyl ﬂuoride, 1 μgml
−1 aprotinin,
1mMNa 3 VO4 and 10mM sodium pyrophosphate [14].
Equal amount of protein as determined by Lowry assay
[28] were diluted with 5× sample loading buﬀer, boiled and
loaded onto 12% polyacrylamide gels. After electrophoresis,
the protein bands were transferred to a nitrocellulose
membrane, and membranes were blocked in 5% milk in
1×TBS, 0.05% Tween, then the transferred bands of AhR,
P C N A ,p 5 3 ,B c l - 2 ,B c l - x L ,B a d ,B a x ,N F - κB (p65 sub-unit
of nuclear extract), cytochrome c,I L - 6a n dc a s p a s e - 9w e r e
bound to their respective monoclonal antibodies purchased
from Abcam, Kendall Square, Cambridge, USA and Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA. Antibodies
for caspase-9, Akt and cytochrome c were purchased from
BD Bioscience, San Jose, CA USA. The bound proteins
were treated with the appropriate ALP-conjugated secondary
antibodies (Sigma Chemicals, St. Louis, MO, USA). The
same membranes were also immunoblotted against β-
actin (house-keeping protein) for data normalization. For
quantitative analysis of each band, density was determined
using Gel Doc System; Ultra Lum, East Uwchlan Ave, Exton,
P A ,U S A ;N o n l i n e a rD y n a m i cL t d ,N e w c a s t l e ,U K .
2.4.2. ELISA. The activity of caspase-3 was measured using
the colorimetric substrate method from skin tissue employ-
ing an ELISA reader (Thermo Scientiﬁc, Vantaa, Finland),
following Das et al. [24]. Cytosolic extracts were prepared
by homogenization of dorsal shaved area of skin tissues4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Histology of skin stained with Haematoxylin/Eosin: (a) normal, (b) DMBA+croton oil+alcohol, (c) DMBA+croton oil+Sec
cor 30-fed; immunoﬂuorescence expression of AhR protein: (d) normal, (e) DMBA+croton oil+alcohol, (f) DMBA+croton oil+Sec cor
30-fed; and PCNA protein localization: (g) normal, (h) DMBA+croton oil+alcohol, (i) DMBA+croton oil+Sec cor 30-fed; (j and k)
represent proportion of average ﬂuorescence intensity of AhR and PCNA protein in diﬀerent groups. ∗∗P <.01.
in extraction buﬀer containing 25mMHEPES (pH 7.5),
5mMMgCl 2,1 m M E D T A ,0 . 1 %( w / v )C H A P Sa n d1 0 μg
aprotinin. Subsequently, the homogenates were centrifuged
at 13000×gf o r1 5 m i na t4 ◦C. The supernatant fraction
was used to determine caspase-3 activity. In brief, caspase-
3 colorimetric substrates (Ac-DEVD-pNA), procured from
Sigma, were incubated with cell lysates for 1h at 37◦C, then
theamountofchromophore,p-nitroaniline (p-NA),releasedEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Immunoblots of β- a c t i n ,A h R ,A k t ,I L - 6 ,N F - κB, PCNA,
Bcl-2, Bcl-xL, Bad, Bax, Apaf and p53, caspase-3 and cytochrome
c. Ln1 represents normal; Ln2 represent DMBA; Ln3 repre-
sents DMBA+croton oil+alcohol; Ln4 represents DMBA+croton
oil+Sec cor 30.
by caspase-3 activity was quantiﬁed by measuring the optical
density at 405 nm. Caspase-3 activity was expressed as μM
p-NA released per hour per milligram cellular protein.
2.5. Cytogenetic Assay. The standard cytogenetic protocols
like assays of chromosome aberrations (CA), micronuclei
(MN), mitotic index (MI) and sperm head anomaly (SHA)
have been adopted in the present study [2, 3].
2.5.1. CA. Slides were prepared by the conventional ﬂame-
drying technique followed by Giemsa staining for scoring
bone marrow CA. A total of 300 bone marrow cells were
observed.
2.5.2. Micronucleus Preparation. One part of the suspension
of bone marrow cells in 1% sodium citrate was smeared on
clean grease-free slides, brieﬂy ﬁxed in methanol and sub-
sequently stained with May-Grunwald followed by Giemsa.
Approximately 3000 bone marrow cells, comprising both
polychromatic erythrocytes and normochromatic erythro-
cytes were scored.
2.5.3. MI. It was determined from the same slide that was
scanned for MN, and a total of 5000 cells were examined
from each series. The non-dividing and dividing cells were
recorded and their ratios ascertained.
2.5.4. SHA. The technique of Wyrobek [29] was adopted.
5000 sperms were examined in each series.
2.5.5. Estimation of DNA Damage. Comet assay was per-
formed with single-cell gel electrophoresis, as per protocol
described elsewhere [30]. Brieﬂy, peripheral blood nuclear
cells (PBMC) (1×104) were suspended in 0.6% low-melting
agarose and layered over a frosted microscopic slide previ-
ously coated with a layer of 0.75% normal-melting agarose
to ensure ﬁrm gripping. The slides were then kept at 4◦C
for solidiﬁcation. Subsequently, slides were immersed in a
lysis buﬀer of pH 10 and kept overnight for lysis of cell and
nuclear membranes. The following day slides were trans-
ferred into a horizontal electrophoresis chamber containing
electrophoresis buﬀer(300mMNaOH, 1mMNa2EDTA; pH
13.0) and presoaked for 20 min in order to unwind DNA.
Electrophoresis was then carried out for 20 min (300 mA,
20 V). Slides were then washed thoroughly with neutralizing
buﬀer (Tris 0.4 M, pH 7.5), stained with ethidium bromide
(ﬁnal concentration of 40μgml
−1) and examined under
a Lyca ﬂuorescence microscope. The percentage of DNA
breakage was determined by measuring the comet tail length
using the software Motic Image China.
2.5.6. Cell-Cycle Analysis. Cellular DNA was stained with
propidium iodide and quantiﬁed by ﬂow cytometry accord-
ing to Nicoletti’sprocedure [31]. Brieﬂy, cells were ﬁxed with
70% (v/v) cold aqueous ethanol (−20◦C) and stored at 4◦C
for at least 24h. The cells were washed in phosphate buﬀer
saline, after cell centrifugation, cell pellets were stained with
propidium iodide staining solution containing 10μgm l
−1
propidium iodide, 5K units of RNase, and 0.1% (v/v) Triton
X-100.Thecellsuspensionwasincubatedinthedarkatroom
temperature for 30 min. DNA content was determined by
using a FACS Calibur ﬂow cytometer (Becton Dickinson,
Mountain View, CA). A total of 40 000 events were acquired,
and MOD-FIT LT software (Becton Dickinson) was used.
2.6. Statistical Analysis. The signiﬁcances of diﬀerences
between data of carcinogen plus 2% alcohol administered
mice and carcinogen administered Sec cor 30-fed mice6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Densitometric data expressed as mean ± SE of the three independent experiments; ∗P <.05, ∗∗P <.01, ∗∗∗P <.001. of β-actin,
AhR, Akt, IL-6, NF-κB, PCNA, Bcl-2, Bcl-xL, Bad, Bax, Apaf, p53, cytochrome c and caspase-9. Each experiment is representative of three
diﬀerent sets of experiments. Ln1 represents normal; Ln2 represents DMBA+croton oil; Ln3 represents DMBA+croton oil+alcohol; Ln4
represents DMBA+croton oil+Sec cor 30.
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were analyzed by the Student’s t-test. For all quantitative
analyses, data were expressed as mean values obtained from
triplicate experiments (on blot and immunoﬂuorescence
studies) showing standard errors and levels of signiﬁcance.
Additionally, the data were also analyzed using one-way
ANOVA (Turkey Method; SPSS version 11).
3.Results
3.1. External Morphology. The changes in external mor-
phology of skin in mice subjected to: (i) no treatment
(Figure 1(a); negative control: Group 1), (ii) carcinogen
treatment (Figure 1(b); Group 2), (iii) carcinogen plus
alcoholtreatment (Figure 1(c); Group 3) and (iv)carcinogen
plus Sec cor 30 treatment (Figure 1(d); Group 4) have been
provided.WhileGroups2and3miceshoweddistinctgrowth
of papilloma, both the Sec cor 30-fed groups showed much
less growth of papilloma as well as loss of hair than their
counterparts who did not receive Sec cor 30 treatment.
The incidence of papilloma growth in diﬀerent weeks in
control and treated mice has been provided in Figure 2.
Papillomas observed in DMBA+ croton oil-treated group
weresigniﬁcantlybiggerinsize (70%papillomasof ≥2.5mM
in diameter) as that of drug-fed series (8%–10%).
3.2. Histology. As compared to the skin section with normal
histological features (Figure 3(a)), irregular distribution of
diﬀerent cell types (e.g., squamous epithelial cells) and
ﬁnger-like projections (papilloma) indicative of cancerous
growth were found in the skin sections of DMBA admin-
istered mice (Figure 3(b)). Tumors of animal belonging to
DMBA+croton oil-treated group were composed of focal
proliferation of squamous cells, presence of some necrotic
cells, keratinization and epithelial pearls, indicative of the
malignant nature of tumors that is characterized by well-
diﬀerentiated squamous cell carcinoma. On the other hand,
in the Sec cor 30-fed mice, these features were visible to a
much lesser extent (Figure 3(c)).
3.3.ImmunoﬂuorescenceStudies. TheAhR-speciﬁc immuno-
chemical staining reveals lack of expression in normal skin
(Figure 3(d)), while in DMBA-treated mice, AhR recep-
tor was seen to take up higher level of green ﬂuores-
cence in DMBA-treated mice without Sec cor 30 feeding
(Figure 3(e)), indicating localization of AhR protein in
carcinogen-treated mice, while in Sec cor 30-fed mice,
the intensity of ﬂuorescence was much less (Figure 3(f)).8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Showing percentage of CA, MN, MI, SHA and DNA damage in diﬀerent groups.∗P < .05, ∗∗P < .01.
Immunoﬂuorescence analysis for PCNA was also used to
assess the proliferation activity in normal (Figure 3(g)),
carcinogen-treated (Figure 3(h)) and in Sec cor 30-fed
groups (Figure 3(i)) during tumor promotion. PCNA is a
proliferating cell nuclear antigen associated with S phase
of DNA replication. It was observed through immunoﬂu-
orescence localization that PCNA expression was higher in
DMBA administrated group, a characteristic intense stain-
ing, as compared to control, was observed (Figure 3(h))a n d ,
also, there was a signiﬁcant modulation of this expression in
Sec cor 30-fed mice. The data on proportion of ﬂuorescence
intensity represented in Figure 3(h) prepared from three
replicates would also validate the above observation.
3.4. Immunoblots. The expression ofdiﬀerentsignal proteins
in normal healthy mice (Group 1) can be observed in the
lane 1 of Figure 4. Of these, the expression level of β-actin,
AhR, Akt, IL-6, NF-κB, PCNA, Bcl-2 and Bcl-xL was of
low level, while it was moderate in Bad, Bax, cytochrome c,
Apaf, p53 and caspase-9. In the DMBA+croton oil-induced
mice, the expression levels were increased in AhR, Akt, IL-
6, NF-κB, PCNA, Bcl-2 and Bcl-xL, while in the carcinogen
administered Sec cor 30-fed mice (Group 4), there was
suppression of the enhanced expression of these signal
proteins. Correspondingly, there was decrease in expression
of proteins like Bad, Bax, Apaf, cytochrome c,c a s p a s e - 9
and p53 in the DMBA+croton oil-induced mice, whichEvidence-Based Complementary and Alternative Medicine 9
Table 1:Percentage ofCA,MN innormal,DMBA+crotonoil,DMBA+crotonoil+alcoholandDMBA+crotonoil+Sec cor30-fed series.
S e r i e s M a j o rC A( % ) O t h e rC A( % ) T o t a lC A( % ) M N( % )
Normal 2.45 2.15 4.60 ± 0.40 0.225 ± 0.08
DMBA+croton oil 12.1 9.7 21.8 ± 0.54 1.13 ± 0.09
DMBA+croton oil+alcohol 14.0 10.3 24.3 ± 0.67 1.22 ± 0.05
DMBA+croton oil+Sec cor 30 10.0 6.67 16.67 ± 1.02∗∗ 0.68 ± 0.06∗∗
MCP-1,monocytechemoattractantprotein-1;VCAM-1,vascularcelladhesionmolecule-1;TGF-β1,tran sfo r min ggr o wthfact o r - β1;GAPD H,gly c eraldeh y de-
3-phosphate dehydrogenase.
Table 2: Flow cytometric analysis of normal, DMBA+croton oil, DMBA+croton oil+alcoholand DMBA+croton oil+drug-treated cells
showingdata of percentage of cells in diﬀerent phases of cell cycle.
Series
Cell-cycle analysis by FACS
SubG1 (%) G1 (%) S (%) G2/M (%)
Normal 32.07 ± 0.375 32.73 ± 0.565 17.44 ± 1.24 2.14 ± 0.020
DMBA+croton oil 23.39 ± 0.005 23.56 ± 0.560 25.73 ± 0.610 6.625 ± 0.375
DMBA+croton oil+alcohol 22.15 ± 0.105 28.41 ± 0.410 28.74 ± 0.640 4.76 ± 0.040
DMBA+croton oil+Sec cor 30 32.68 ± 0.310∗ 31.88 ± 0.995∗ 19.44 ± 1.16∗∗ 2.18 ± 0.28∗∗∗
Values are expressed as mean ± SE. Data are the means of the results from two independent experiments. Comparisons are made between carcinogen treated
and drug fed mice. ∗P < .05, ∗∗P <.01; ∗∗∗P <.001.
were increased in the Sec cor 30-fed mice. Quantiﬁcation
of proteins was done by densitometry using image analyzer,
shown in Figure 5.
3.5.Caspase-3 ActivitythroughELISA. The caspase-3 activity
was higherinSeccor30-fedmiceascomparedtotheDMBA-
administered mice (Figure 6).
3.6. Cytogenetical Studies. The frequency distributions of
CA,MN havebeenprovidedin Table 1.W h i l et h ep e r c e n t a g e
of CA, MN, MI and SHA (Figure 7)w e r es i g n i ﬁ c a n t l y
elevated in the DMBA-induced mice as compared to normal
untreated control, the values were signiﬁcantly decreased by
the feeding of Sec cor 30. The same was supported by the
data of Comet assay (Figure 7)t h a ti n d i c a t e dam u c hm o r e
amountofbrokenDNAinmicetreatedwithDMBA+croton
oil, but much less in the Sec cor 30-fed mice.
3.7. Cell-Cycle Analysis by FACS. The FACS analysis revealed
that in the Sec cor 30-fed mice, the cell cycle was arrested
more in the sub-G1 stage (32%) than that of the DMBA
treated mice (23%). Furthermore, DMBA showed higher
percentageofSphase (25%)in contrastto the Seccor30 that
showed 19% of cells in S phase (Table 2).
4.Discussion
A sf a ra sa u t h o r sa r ea w a r e ,t h i si st h eﬁ r s td e m o n s t r a -
tion where a potentized homeopathic drug diluted beyond
Avogadro’s limit, Secale cor 30, successfully reduced the
incidence of DMBA-induced skin papilloma in mice. The
histological features of skin of the drug-fed group showed
evidence of amelioration rendered by the administration of
the homeopathicdrug. Similarﬁndings ofamelioration were
also reported incase ofothertypesofcancerlikeliverin mice
through the administration of some crude plant extracts
used as homeopathic mother tincture [2, 3]o ri ns k i nc a n c e r
by an anti-mitotic agent like 4-demethyl epipodophyllotoxin
[32].
DMBA is a pro-carcinogen that requires metabolic
conversion to its ultimate carcinogenic metabolite 3,4-
dihydrodiol-1,2-epoxide [33]. These metabolites damage
DNA presumably by formation of adducts, which could be
evidenced by the increase in comet tail lengths and elevated
frequencies of chromosomal aberrations in the carcinogen-
administeredmice.TheDNAdamage,CAand,consequently,
disorder in metabolic functioning, contributed to the ini-
tiation of the tumorigenic process, through generation of
ROS. The generation of ROS contributed further to the
up-regulation of several downstream signaling proteins like
NF-κB, Akt and PCNA. Up-regulation of NF-κB would
induce the anti-apoptotic Bcl-2 and Bcl-xL genes through
up-regulated Akt and thereby prevent the cells to undertake
the apoptotic pathway via down-regulation of pro-apoptotic
genes Bad, Bax and Apaf, caspase-3 and -9.
The AhR is known to be involved in the induction of
several enzymes that participate in xenobiotic metabolism.
Induction of enzymes involved in xenobiotic metabolism
occurs through binding of the ligand-bound AhR to xeno-
biotic response elements in the promoters of gene for these
enzymes [34, 35]. The AhRprotein contains several domains
critical for function and act as a variety of transcription
factors. Two PAS domains are also present in AhR, PAS-A
and PAS-B [36]. The ligand-binding site of AhR is contained
within the PAS-B domain and contains several conserved
residuescriticalforligandbinding[37].ThereisalsoaQ-rich
domain located in the C terminal region of the protein and is10 Evidence-Based Complementary and Alternative Medicine
involvedin the co-activator recruitment and trans-activation
[38].
Toxicity results from two diﬀerentwaysofAhRsignaling.
T h eﬁ r s ti saf u n c t i o no ft h ea d a p t i v er e s p o n s ei nw h i c ht h e
induction of metabolizing enzymes result in the production
of toxic metabolites, as for example the PAH, benz[a]pyrine,
a hydrocarbon for AhR induces its own metabolism and
bioactivation to toxic metabolites via the induction of
CYP1A1 and CYP1B1 in several tissues [18]. The second
approach to the toxicity is the result of aberrant changes in
global gene transcription beyond those observed in the “AhR
gene battery.”
Our present ﬁndings agree well to the reported fact that
the DMBA-induced cell signaling mechanism is mediated
by up-regulation of AhR. Our studies on several anti-
oxidant markers like catalase, superoxide dismutase, lipid
peroxidation and reduced glutathione (results unpublished)
also suggested that there was the generation of reactive
oxygen species (ROS) on application of DMBA. We found
up-regulation in expression of some genes like IL-6, NF-
κB, Bcl-2 and Bcl-xL that may be responsible for leading
to proliferation of cells, which in turn is reﬂected on an
increase in PCNA in the drug-untreated mice. The increase
in PCNA was accompanied by down-regulation of p53, Bax
and caspase-3 genes, for which epidermal skin cells (ker-
atinocytes) started uncontrolled divisions to subsequently
form papilloma. The immunochemical localization also
suggested that there was excess amount of the enzymes
involving the products of unregulated genes.
Interestingly, in the drug-fed mice, very clear indication
of modulation in the expression of the genes was noticed.
The AhR expression was signiﬁcantly lowered. Signiﬁcant
changes were also noted in the expression of IL-6, NF-κB,
Bcl-2, Bcl-xL and PCNA, which were reversed. Secale cor
30 administration caused up-regulation in the expression
of p53, Bax, Apaf, caspase-3 and -9 and down-regulation
of PCNA. This was a good indicator of the lower state of
proliferation of the cells. This was further conﬁrmed by
our analysis of the FACS data, which showed more number
of cells in the sub-G1 and G1 stages of the cycle. This
tempted us to believe that the potentized homeopathic drug
Sec cor-30 was possibly tagged in an unknown manner to
some regulatory proteins. This binding with an unknown
protein could give it the ability to bind on the AhR, thereby
competitively reducing space for DMBA-binding that was
responsible for lowering activity of AhR in the drug fed
mice. Alternatively, it prevented the conversion of DMBA
into the lesser amount of carcinogenic metabolites. Thus,
the homeopathic drug apparently fulﬁlled the function of
‘ligand’ by its ability to modulate the AhR activity. This
was further conﬁrmed by results of our immunoﬂuorscence
assay. Incidentally, nanoparticles associated with molecules
of drug substance have been shown to aﬀect the physico-
chemical property of potentized homeopathic drugs [15].
Nanoparticles of glass vial and other containers are also
known to form complexes with various proteins and in
some cases, in the process change their physicochemical
properties [39]. Therefore, it is possible that the potentized
homeopathic drug Secale cor 30, theoretically devoid of the
presence of even a single molecule of the original drug
substance,wasstillcapableofapparentlyinitiatingbindingto
AhR, presumably through some activated proteins, because
it is a pre-condition for Ahr to be ligand-activated before
it could stimulate downstream proteins. However, the other
possibility that cannot be excluded is the ability of Sec
cor 30 to have regulatory inﬂuences on the other gene
products directly or through indirect means. But one thing
is clear from this study that potentized homeopathic drug
does elicit regulatory inﬂuences on expression of certain
relevant genes that can interfere with the carcinogenic eﬀect
of DMBA+croton oil in ameliorating/protecting skin cells
from being transformed into skin papilloma (as evidenced
from the diﬀerence in expression of several signal proteins),
although one may still argue that it is diﬃcult to attribute
the biochemical diﬀerences between tumor and normal cells
to a causal mechanism or secondary consequences for cell
transformation. Therefore,furtherin-depthstudy,preferably
with global micro-array methodology, may transpire that
expression ofmany otherrelevant downstream protein genes
can also be modulated. Incidentally, like what has been
found in the present study in regard to speciﬁc signal
proteins, modulation of some 147 downstream genes by
a homeopathic drug has been reported by analysis of
microarray [40], giving much credentials to the postulation
of Khuda-Bukhsh [10–12, 41].
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